Claude El Kouri
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Genetics top 10%
- Cancer Research top 10%
- Co-authors
- Éric LegouffeC. BourgierClaire CropetMarc DebledGilles FreyerSophie Abadie‐LacourtoisieDominique SpaëthThomas Bachelot
- Topics
- Virus-based gene therapy research (4 papers)Cancer Treatment and Pharmacology (4 papers)Lung Cancer Treatments and Mutations (4 papers)
- Partner nations
- FranceUnited StatesIndia
In The Last Decade
Claude El Kouri
18 papers receiving 881 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 507
- Pulmonary and Respiratory Medicine 495
- Molecular Biology 429
- Genetics 204
- Cancer Research 178
Countries citing papers authored by Claude El Kouri
This map shows the geographic impact of Claude El Kouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude El Kouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude El Kouri more than expected).
Fields of papers citing papers by Claude El Kouri
This network shows the impact of papers produced by Claude El Kouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude El Kouri. The network helps show where Claude El Kouri may publish in the future.
Co-authorship network of co-authors of Claude El Kouri
This figure shows the co-authorship network connecting the top 25 collaborators of Claude El Kouri. A scholar is included among the top collaborators of Claude El Kouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude El Kouri. Claude El Kouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 34 | |
| 3 | 9 | |
| 4 | 3 | |
| 5 | 10 | |
| 6 | 24 | |
| 7 | 40 | |
| 8 | 3 | |
| 9 | 27 | |
| 10 | 1 | |
| 11 | 28 | |
| 12 | Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Studybreakdown → | 539 |
| 13 | 0 | |
| 14 | 6 | |
| 15 | 45 | |
| 16 | 9 | |
| 17 | 30 | |
| 18 | 28 | |
| 19 | 41 | |
| 20 | 26 |
About Claude El Kouri
Claude El Kouri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 20 papers that have together received 903 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (507 citations), Pulmonary and Respiratory Medicine (495 citations) and Cancer Research (178 citations). Claude El Kouri has collaborated with scholars based in France, United States and India. Frequent co-authors include Éric Legouffe, C. Bourgier, Claire Cropet, Marc Debled, Gilles Freyer, Sophie Abadie‐Lacourtoisie, Dominique Spaëth, Thomas Bachelot, Isabelle Ray‐Coquard and Jean-Marc Ferrero. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.